SCHEMBL19634018

SCHEMBL19634018

COc1ccc(CN(Sc2ccc(F)c(Cl)c2)c2cccc(F)n2)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
MAPT P10636 4/20 0.39
KDM4E B2RXH2 3/20 0.37
HTR2A P28223 1/20 0.36
SLC6A4 P31645 1/20 0.36
KCNH2 Q12809 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35
ALDH1A1 P00352 5/20 0.34
CYP3A4 P08684 4/20 0.34
CYP2C19 P33261 4/20 0.34
TSHR P16473 4/20 0.34
LMNA P02545 3/20 0.34
CYP1A2 P05177 3/20 0.34
CYP2D6 P10635 3/20 0.34
CLK4 Q9HAZ1 2/20 0.34
GLA P06280 1/20 0.34
CYP2C9 P11712 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21783445 0.87 CYP1A2 (0.35) MEN1KMT2AMAPTKDM4EHTR2A
SCHEMBL19634258 0.86 HTR2A (0.38) MEN1KMT2AMAPTKDM4EHTR2A
SCHEMBL20256741 0.82 KMT2A (0.35) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL19634068 0.82 MEN1 (0.38) MEN1KMT2AMAPTKDM4EHTR2A
SCHEMBL21783395 0.82 KMT2A (0.36) MEN1KMT2AKDM4EALDH1A1CYP3A4
SCHEMBL19633903 0.80 MEN1 (0.40) MEN1KMT2AMAPTKDM4EHTR2A
SCHEMBL21783444 0.79 KMT2A (0.37) MEN1KMT2AMAPTKDM4EHTR2A
SCHEMBL21783377 0.78 MEN1 (0.37) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL19634006 0.78 DHFR (0.36) MEN1KMT2AMAPTKDM4EHTR2A
SCHEMBL19633978 0.78 MEN1 (0.38) MEN1KMT2AMAPTKDM4EHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed